iCeutica Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

iCeutica General Information

Description

Manufacturer and provider of branded medicines. The company offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Kew Place
  • 150 Rouse Boulevard, Navy Yard Corporate Center
  • Philadelphia, PA 19112
  • United States
+1 (267)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • One Kew Place
  • 150 Rouse Boulevard, Navy Yard Corporate Center
  • Philadelphia, PA 19112
  • United States
+1 (267)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iCeutica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Apr-2011 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series D) 16-Mar-2011 Completed Clinical Trials - Phase 3
3. Later Stage VC 08-Jul-2010 Completed Generating Revenue
2. Early Stage VC (Series B) 30-Jun-2007 $1.09M $2.09M Completed Generating Revenue
1. Early Stage VC (Series A) 21-Jun-2005 $1M $1M Completed Product Development
To view iCeutica’s complete valuation and funding history, request access »

iCeutica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 2,325,000 $0.001000 $0.05 $1 $1 1x $1 47.8%
To view iCeutica’s complete cap table history, request access »

iCeutica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and provider of branded medicines. The company offers SoluMatrix platform, a drug reformulation and deliver
Drug Discovery
Philadelphia, PA

Baton Rouge, LA
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iCeutica Competitors (5)

One of iCeutica’s 5 competitors is OncBioMune Pharmaceuticals, a Corporate Backed or Acquired company based in Baton Rouge, LA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncBioMune Pharmaceuticals Corporate Backed or Acquired Baton Rouge, LA
Alkermes Formerly VC-backed Dublin, Ireland
ReveraGen BioPharma Formerly VC-backed Rockville, MD
BioDelivery Sciences International Private Equity-Backed Raleigh, NC
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 5 competitors. Get the full list »

iCeutica Patents

iCeutica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016044701-A1 Abiraterone acetate formulation and methods of use Inactive 18-Sep-2014
US-20230414630-A1 Novel formulation of meloxicam Inactive 09-Jun-2014
US-20150157646-A1 Abiraterone steroid formulation Inactive 27-Sep-2013
AU-2014293193-A1 Formulation of metaxalone Inactive 22-Jul-2013
CA-2918908-A1 Formulation of metaxalone Inactive 22-Jul-2013 C07D263/24
To view iCeutica’s complete patent history, request access »

iCeutica Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
PIPV Capital PE/Buyout Minority
To view iCeutica’s complete investors history, request access »

iCeutica FAQs

  • When was iCeutica founded?

    iCeutica was founded in 2003.

  • Where is iCeutica headquartered?

    iCeutica is headquartered in Philadelphia, PA.

  • What industry is iCeutica in?

    iCeutica’s primary industry is Drug Discovery.

  • Is iCeutica a private or public company?

    iCeutica is a Private company.

  • What is iCeutica’s current revenue?

    The current revenue for iCeutica is .

  • How much funding has iCeutica raised over time?

    iCeutica has raised $5.67M.

  • Who are iCeutica’s investors?

    PIPV Capital has invested in iCeutica.

  • Who are iCeutica’s competitors?

    OncBioMune Pharmaceuticals, Alkermes, ReveraGen BioPharma, BioDelivery Sciences International, and Novartis are competitors of iCeutica.

  • When was iCeutica acquired?

    iCeutica was acquired on 28-Apr-2011.

  • Who acquired iCeutica?

    iCeutica was acquired by Iroko Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process